Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Share Save Share Save Improved glycaemic control and weight benefit with iGlarLixi versus insulin glargine 100 U/mL in Chinese people with type 2 diabetes advancing their therapy from basal insulin plus oral antihyperglycaemic drugs: Results from the LixiLan-L-CN randomized controlled trial
Yuan, Xiaoyong; Guo, Xiaohui; Zhang, Junqing; Dong, Xiaolin; Lu, Yibing; Pang, Wuyan; Gu, Shenghong; Niemoeller, Elisabeth; Ping, Lin; Nian, Gaowei; Souhami, Elisabeth Share Save Risk Factors for Diabetic Peripheral Neuropathy, Peripheral Artery Disease, and Foot Deformity Among the Population With Diabetes in Beijing, China: A Multicenter, Cross-Sectional StudyLiu, Jiayi; Yuan, Xiaoyong; Liu, Jin; Yuan, Geheng; Sun, Yalan; Zhang, Donghui; Qi, Xin; Li, Huijuan; Zhang, Junqing; Wen, Bing; Guo, Xiaohui Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save An Analysis of Correlative Factors of HbA1c Achieving Rate in Follow-Up Cohort of Internet plus Diabetes Shared Care ClinicLi, Ang; Yuan, Xiaoyong; Lin, Liu; Lu, Difei; Zhang, Donghui; Sun, Yalan; Li, Jun; Jing, Lulu; Wang, Yanni; Guo, Xiaohui Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
